Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0159870003
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Marketed | 02497581 | NOVO NORDISK CANADA INC | RYBELSUS | Human | Yes | Schedule D | 1 | SEMAGLUTIDE | 3 MG |
Marketed | 02497581 | NOVO NORDISK CANADA INC | RYBELSUS | Human | Yes | Prescription | 1 | SEMAGLUTIDE | 3 MG |
Approved | 02522608 | NOVO NORDISK CANADA INC | WEGOVY | Human | Yes | Schedule D | 1 | SEMAGLUTIDE | 2.4 MG / 0.75 ML |
Approved | 02522608 | NOVO NORDISK CANADA INC | WEGOVY | Human | Yes | Prescription | 1 | SEMAGLUTIDE | 2.4 MG / 0.75 ML |
Marketed | 02528541 | NOVO NORDISK CANADA INC | WEGOVY | Human | Yes | Schedule D | 1 | SEMAGLUTIDE | 9.6 MG / 3 ML |
Marketed | 02528541 | NOVO NORDISK CANADA INC | WEGOVY | Human | Yes | Prescription | 1 | SEMAGLUTIDE | 9.6 MG / 3 ML |
Application information
Related information
Contact us
Version 4.0.3